COVID-19 and stroke: a case report

Year 2020, Volume: 6 Issue: 4, 343 - 346, 04.07.2020

Ensar Durmuş , Fatih Güneysu

https://doi.org/10.18621/eurj.719715

Abstract

COVID-19 disease is a worldwide pandemic. Patients present to hospitals with upper and lower respiratory tract symptoms such as cough, fever, shortness of breath, however it can also be encountered with many different clinics. We aimed to share the patient who has COVID-19 and presented with stroke. A 67-year-old female patient presented to the emergency service complaints of mental fog and shortness of breath. She had known lung cancer, hypertension and diabetes. There were no signs compatible with COVID-19 in her history or examination. No feature was detected in her blood tests. Diffuse cerebral infarction was observed in diffusion MRI examination. The patient, whose general condition was poor, was taken into follow up in intensive care unit. On the eighth day of her follow-up, the patient passed away. In places where COVID-19 disease is observed commonly, it would be appropriate for emergency physicians to take COVID-19 disease into consideration in stroke cases. 

Keywords

COVID-19, stroke, pandemic

References

• 1. Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke: a case report. 2020 Mar 31 [cited 2020 Apr 12]; Available from: https://www.researchsquare.com/article/rs-20393/v1.
• 2. Xu JF, Wang L, Zhao L, Li F, Liu J, Zhang L, et al. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. 2020 Mar 24 [cited 2020 Apr 12]; Available from: https://www.researchsquare.com/article/rs-18340/v1.
• 3. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023-6.
• 4. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844-7.
• 5. Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev 2020;19:102538.
• 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
• 7. Bermejo-Martin JF, Almansa R, Menéndez R, Mendez R, Kelvin DJ, Torres A. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. J Infect 2020;80:e23-4.
• 8. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, et al. [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia]. Zhonghua Xue Ye Xue Za Zhi 2020;41:302-7. [Article in Chinese]
• 9. Davies NA, Harrison NK, Sabra A, Lawrence MJ, Noble S, Davidson SJ, et al. Application of ROTEM to assess hypercoagulability in patients with lung cancer. Thromb Res 2015;135:1075-80.
• 10. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020:e3319.
• 11. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: what we know. J Am Geriatr Soc 2020;68:926-9.